Circulation Journal
Online ISSN : 1347-4820
Print ISSN : 1346-9843
ISSN-L : 1346-9843
Valvular Heart Disease
Age-Related Differences in the Effects of Initial Aortic Valve Replacement vs. Conservative Strategy on Long-Term Outcomes in Asymptomatic Patients With Severe Aortic Stenosis
Akihiro KushiyamaTomohiko TaniguchiTakeshi MorimotoHiroki ShiomiKenji AndoNorio KanamoriKoichiro MurataTakeshi KitaiYuichi KawaseChisato IzumiMakoto MiyakeHirokazu MitsuokaMasashi KatoYutaka HiranoShintaro MatsudaTsukasa InadaKazuya NagaoHiroshi MabuchiYasuyo TakeuchiKeiichiro YamaneMamoru ToyofukuMitsuru IshiiEri Minamino-MutaTakao KatoMoriaki InokoTomoyuki IkedaAkihiro KomasaKatsuhisa IshiiKozo HottaNobuya HigashitaniYoshihiro KatoYasutaka InuzukaToshikazu JinnaiYuko MorikamiNaritatsu SaitoKenji MinatoyaTakeshi Kimuraon behalf of the CURRENT AS Registry Investigators
Author information
JOURNAL FREE ACCESS FULL-TEXT HTML
Supplementary material

2020 Volume 84 Issue 2 Pages 252-261

Details
Abstract

Background:This study aimed to evaluate the effect of the initial aortic valve replacement (AVR) strategy relative to a conservative strategy on long-term outcomes stratified by age among asymptomatic patients with severe aortic stenosis (AS).

Methods and Results:Among 1,808 asymptomatic severe AS patients in the CURRENT AS registry, there were 1,166 patients aged ≥75 years (initial AVR: n=124, and conservative: n=1,042), and 642 patients with age <75 years (initial AVR: n=167, and conservative: n=475). Median follow-up interval was 1,280 (interquartile range [IQR]: 1,012–1,611) days, and 1461 (IQR: 1,132–1,886) days in patients aged ≥ and <75 years, respectively. The favorable effect of the initial AVR strategy relative to conservative strategy for heart failure (HF) hospitalization was seen regardless of the age stratum (≥75 years: adjusted hazard ratio [HR] 0.13, 95% confidence interval [CI] 0.05–0.34, and <75 years: HR 0.37, 95% CI 0.14–0.99, interaction P=0.35). However, the lower mortality risk of the initial AVR strategy relative to conservative strategy was significant in patients aged ≥75 years, but not in patients <75 years, with significant interaction (HR 0.35, 95% CI 0.20–0.61, and HR 0.69, 95% CI 0.41–1.16, interaction P=0.016).

Conclusions:The benefit of initial AVR in reducing HF hospitalization in asymptomatic patients with severe AS was consistently seen regardless of age. The magnitude of mortality benefit of initial AVR was greater in super-elder patients than in non-super-elder patients.

Content from these authors
© 2020 THE JAPANESE CIRCULATION SOCIETY
Previous article Next article
feedback
Top